FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37021911000001100: Risankizumab (substance)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    39461000001110 Risankizumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
    39471000001117 Risankizumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Risankizumab Is a Monoclonal antibody false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Risankizumab 75mg/0.83ml solution for injection pre-filled syringes Has specific active ingredient False Risankizumab Inferred relationship Existential restriction modifier
    Skyrizi 75mg/0.83ml solution for injection pre-filled syringes (AbbVie Ltd) Has specific active ingredient False Risankizumab Inferred relationship Existential restriction modifier
    Skyrizi 75mg/0.83ml solution for injection pre-filled syringes (AbbVie Ltd) 2 pre-filled disposable injection Has specific active ingredient False Risankizumab Inferred relationship Existential restriction modifier
    Risankizumab 75mg/0.83ml solution for injection pre-filled syringes 2 pre-filled disposable injection Has specific active ingredient False Risankizumab Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start